31
Views
39
CrossRef citations to date
0
Altmetric
Original Article

Carnitine and left ventricular function in haemodialysis patients

, , , , &
Pages 193-198 | Received 13 Jun 1984, Accepted 02 Oct 1984, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

G. F. Romagnoli, A. Naso, G. Carraro & V. Lidestri. (2002) Beneficial Effects of L-Carnitine in Dialysis Patients with Impaired Left Ventricular Function: An Observational Study. Current Medical Research and Opinion 18:3, pages 172-175.
Read now
Birger Fagher, Mario Monti, Peter Nilsson-Ehle & Hans Thysell. (1987) Reduced thermogenesis in muscle and disturbed lipoprotein metabolism in relation to thyroid function in haemodialysis patients. Scandinavian Journal of Clinical and Laboratory Investigation 47:1, pages 91-97.
Read now

Articles from other publishers (37)

Norihiro Nishioka, Yan Luo, Takuya Taniguchi, Tsuyoshi Ohnishi, Miho Kimachi, Roland CK Ng & Norio Watanabe. (2022) Carnitine supplements for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews 2022:12.
Crossref
Nikayla Patel, Muhammad Magdi Yaqoob & Dunja Aksentijevic. (2022) Cardiac metabolic remodelling in chronic kidney disease. Nature Reviews Nephrology 18:8, pages 524-537.
Crossref
Api Chewcharat, Pol Chewcharat, Weitao Liu, Jacqueline Cellini, Elizabeth A. Phipps, Jill A. Melendez Young & Sagar U. Nigwekar. (2022) The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis. PLOS ONE 17:7, pages e0271307.
Crossref
Norihiro Nishioka, Yan Luo, Takuya Taniguchi, Tsuyoshi Ohnishi, Miho Kimachi, Roland CK Ng & Norio Watanabe. (2020) Carnitine supplements for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews.
Crossref
Junko Naito, Hiroshige Ohashi, Michiya Ohno, Masafumi Sugiyama, Kazuyoshi Hayakawa, Akihisa Kunishima, Nobuyuki Takada, Tatsuya Kariya, Koshi Goto, Hisato Takatsu, Toshiki Ohira, Koji Nakahara, Ichijiro Murata, Shingo Minatoguchi, Gakuro Yoshida, Hiroyuki Okura & Shinya Minatoguchi. (2019) Long-Term Levocarnitine Ameliorates Left Ventricular Diastolic as Well as Systolic Dysfunction in Hemodialysis Patients ― Multi-Center Study ―. Circulation Reports 1:11, pages 508-516.
Crossref
Takashi Maruyama & Masanori Abe. (2018) Effects of Levocarnitine Treatment on the Cardiac Function in Hemodialysis Patients. Internal Medicine 57:24, pages 3503-3505.
Crossref
Zhi-Cheng Jing, Bing-Xiang Wu, Jian-Qiang Peng, Xin-Li Li, Lei Pan, Shui-Ping Zhao, Dong-Ye Li, Zai-Xin Yu, Jian-Bin Gong, Qing-Yan Zhao, Jia-Ning Cao, Guo-Tai Sheng, Jue Li, Benjamin Xiaoyi Li, Su Jiang, Chaofan Liang, Erika Salvi & Valentina Carubelli. (2016) Effect of intravenous l-carnitine in Chinese patients with chronic heart failure. European Heart Journal Supplements 18:suppl A, pages A27-A36.
Crossref
Terumi Higuchi, Masanori Abe, Toshio Yamazaki, Erina Okawa, Hideyuki Ando, Sunao Hotta, Osamu Oikawa, Fumito Kikuchi, Kazuyoshi Okada & Masayoshi Soma. (2016) Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial. American Journal of Kidney Diseases 67:2, pages 260-270.
Crossref
Yizhi Chen, Manuela Abbate, Li Tang, Guangyan Cai, Zhixiang Gong, Ribao Wei, Jianhui Zhou & Xiangmei Chen. (2014) l-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis. The American Journal of Clinical Nutrition 99:2, pages 408-422.
Crossref
Kristen Sgambat, Lowell Frank, Ahmad Ellini, Craig Sable & Asha Moudgil. (2012) Carnitine supplementation improves cardiac strain rate in children on chronic hemodialysis. Pediatric Nephrology 27:8, pages 1381-1387.
Crossref
Lorenzo A. Calò, Ugo Vertolli, Paul A. Davis & Vincenzo Savica. (2012) L carnitine in hemodialysis patients . Hemodialysis International 16:3, pages 428-434.
Crossref
Seung-Jung Kim. (2012) The Effects of Carnitine Supplementation in Hemodialysis Patients. The Ewha Medical Journal 35:2, pages 89.
Crossref
Alaa A. Sabry, Osama Ghaith, Tarek Medhat, Shahir K. George & Eid E. Elshafey. (2009) Is there a Role for Oral L-Carnitine Therapy in Anemia and Cardiac Dysfunction Management in Egyptian Patients on Maintenance Hemodialysis?. Electronic Journal of General Medicine 6:2, pages 60-68.
Crossref
Katherine E. Lynch, Harold I. Feldman, Jesse A. Berlin, James Flory, Christopher G. Rowan & Steven M. Brunelli. (2008) Effects of l-Carnitine on Dialysis-Related Hypotension and Muscle Cramps: A Meta-analysis. American Journal of Kidney Diseases 52:5, pages 962-971.
Crossref
Tai Sakurabayashi, Shigeru Miyazaki, Yasuko Yuasa, Shinji Sakai, Masashi Suzuki, Sachio Takahashi & Yoshihei Hirasawa. (2008) L-Carnitine Supplementation Decreases the Left Ventricular Mass in Patients Undergoing Hemodialysis. Circulation Journal 72:6, pages 926-931.
Crossref
STEPHANIE E REUTER, RANDALL J FAULL & ALLAN M EVANS. (2007) L-carnitine supplementation in the dialysis population: Are Australian patients missing out?. Nephrology 0:0, pages 070712161837003-???.
Crossref
S. Susan Hedayati. (2006) HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Dialysis-Related Carnitine Disorder. Seminars in Dialysis 19:4, pages 323-328.
Crossref
Brook Belay, Nora Esteban-Cruciani, Christine A. Walsh & Frederick J. Kaskel. (2005) The use of levo-carnitine in children with renal disease: a review and a call for future studies. Pediatric Nephrology 21:3, pages 308-317.
Crossref
Brian Schreiber. (2017) Levocarnitine and Dialysis: A Review. Nutrition in Clinical Practice 20:2, pages 218-243.
Crossref
MENOTTI CALVANI, PAOLA BENATTI, ANGELO MANCINELLI, STEFANIA D'IDDIO, VINCENZO GIORDANO, ALEARDO KOVERECH, ANTONINO AMATO & ERIC P. BRASS. (2004) Carnitine Replacement in End-Stage Renal Disease and Hemodialysis. Annals of the New York Academy of Sciences 1033:1, pages 52-66.
Crossref
Drukker, Parsons & MaherW. H. Hörl. 2004. Replacement of Renal Function by Dialysis. Replacement of Renal Function by Dialysis 927 963 .
Brian D. Schreiber. (2003) Congestive Heart Failure in Patients with Chronic Kidney Disease and on Dialysis. The American Journal of the Medical Sciences 325:4, pages 179-193.
Crossref
Daniel F Pauly & Carl J Pepine. (2003) The role of carnitine in myocardial dysfunction. American Journal of Kidney Diseases 41, pages S35-S43.
Crossref
Jean-Marc Hurot, Michel Cucherat, Margaret Haugh & Denis Fouque. (2002) Effects of l-Carnitine Supplementation in Maintenance Hemodialysis Patients: A Systematic Review. Journal of the American Society of Nephrology 13:3, pages 708-714.
Crossref
Suhail Ahmad. (2001) L‐Carnitine in Dialysis Patients. Seminars in Dialysis 14:3, pages 209-217.
Crossref
. (2000) I. Adult guidelines. American Journal of Kidney Diseases 35:6, pages s17-s104.
Crossref
Stefan Thomas, Frank-Peter Fischer, Thomas Mettang, Christiane Pauli-Magnus, Jochen Weber & Ulrich Kuhlmann. (1999) Effects of L-carnitine on leukocyte function and viability in hemodialysis patients: A double-blind randomized trial. American Journal of Kidney Diseases 34:4, pages 678-687.
Crossref
REZAN TOPALOǴLU, ALPAY ÇELIKER, ÜMIT SAATÇI, KAMER KLINÇ, AYÇIN BAKKALOǴLU, NESRIN BEşBAS & KÜRSdedilAT TOKEL. (2007) Effect of carnitine supplementation on cardiac function in hemodialyzed children. Pediatrics International 40:1, pages 26-29.
Crossref
Thomas A. Golper & Suhail Ahmad. (2007) L‐Carnitine Administration to Hemodialysis Patients: Has Its Time Come?. Seminars in Dialysis 5:2, pages 94-98.
Crossref
N. BazilinskiG. Dunea. (2018) Carnitine: An Overview. The International Journal of Artificial Organs 13:11, pages 720-722.
Crossref
Suhail Ahmad, H. Thomas Robertson, Thomas A. Golper, Marsha Wolfson, Paul Kurtin, Lois A. Katz, Raimund Hirschberg, Robert Nicora, Donald W. Ashbrook & Joel D. Kopple. (1990) Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney International 38:5, pages 912-918.
Crossref
Paul S. Kurtin. (2007) Carnitine Metabolism and Usage in Chronic Dialysis Patients. Seminars in Dialysis 3:3, pages 166-170.
Crossref
Peter Fürst, Anne Glöggler & Claudia Rössle. 1990. New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis. New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis 69 77 .
K. Lundholm, H. Persson & A. Wennberg. (2008) Whole body fat oxidation before and after carnitine supplementation in uremic patients on chronic haemodialysis. Clinical Physiology 8:4, pages 417-426.
Crossref
H. R. Scholte, I. E. M. Luyt-Houwen & M. H. M. Vaandrager-Verduin. 1987. Lipid metabolism in the normoxic and ischaemic heart. Lipid metabolism in the normoxic and ischaemic heart 63 73 .
Barry S. Kendler. (1986) Carnitine: An overview of its role in preventive medicine. Preventive Medicine 15:4, pages 373-390.
Crossref
C. Wanner & W. H. Hörl. (1986) Potential role of carnitine in patients with renal insufficiency. Klinische Wochenschrift 64:13, pages 579-586.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.